In the Middle East and Africa pharmaceutical industry, there were 16 M&A deals announced in Q3 2024, worth a total value of $1.8bn, according to GlobalData’s Deals Database. The $1.7bn acquisition of V-Wave by Johnson & Johnson was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2024 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.

Smarter leaders trust GlobalData

In value terms, M&A activity in Middle East and Africa increased by 15285% in Q3 2024 compared with the previous quarter’s total of $11.7m and rose by 1163% as compared to Q3 2023. Related deal volume increased by 167% in Q3 2024 versus the previous quarter and was 78% higher than in Q3 2023.

The top-ranked financial advisors supporting these M&A deals in Middle East and Africa in 9M 2024 were Bank AlJazira; A.G.P./Alliance Global Partners; Cohen with 2, 1, 1 deals respectively.

The top-ranked legal advisors supporting these M&A deals in Middle East and Africa in 9M 2024 were Meitar Law Offices; Fenwick & West; Goodwin Procter with 3, 1, 1 deals respectively.

For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q3 2024 – Strategic Intelligence, buy the report here.

This content was updated on 19 October 2024

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.